Piraxelate

This classification denotes a vasodilating agent with the molecular formula C15H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y1P25NQI7X, chemically known as 3,3,5-trimethylcyclohexyl-2-oxo-1-pyrrolidineacetate. but generally known as piraxelate, which bears US NIH Compound Identifier 3047851. European Medicines Agency schedules Piraxelate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09895MIG. The term PIRAXELATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). PIRAXELATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piraxelate under HS 29337900 and SITC 51561. As of Q4 2014, PIRAXELATE remains the US FDA Preferred Term for this commodity. Piraxelate bears US NLM identifiers UMLS ID C1882392 and NCI Concept Code C66412. SMILES: O(C1CC(CC(C1)C)(C)C)C(=O)CN1CCCC1=O.